BridgeBio Pharma (BBIO) Dividends Paid - Common (2019)

BridgeBio Pharma (BBIO) reported Dividends Paid - Common of $54.0 million for Q4 2019, up 5317.65% sequentially from $997000.0 in Q1 2019.

BridgeBio Pharma (BBIO) Dividends Paid - Common (2019) Analysis & Trends

BridgeBio Pharma (BBIO) has 1 years of Dividends Paid - Common data on file, last reported at $54.0 million in Q4 2019.

For the quarter ending Q4 2019, Dividends Paid - Common changed N/A year-over-year to $54.0 million; the trailing twelve-month figure through Dec 2019 stood at $55.0 million (changed N/A YoY), and the FY2020 full-year result was $5.0 million, down 90.91% from the prior year.
Dividends Paid - Common rose to $54.0 million in Q4 2019, from $997000.0 in the prior quarter.
In the past five years, Dividends Paid - Common ranged from a high of $54.0 million in Q4 2019 to a low of $997000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends Paid - Common (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	97.80 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	BridgeBio Pharma	16.15 Bn	15.22 Bn	184.58 Mn	-

Download Data